BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30914224)

  • 1. Vaccine-mediated protection of pigs against infection with pandemic H1N1 2009 swine influenza A virus requires a close antigenic match between the vaccine antigen and challenge virus.
    Everett HE; Aramouni M; Coward V; Ramsay A; Kelly M; Morgan S; Tchilian E; Canini L; Woolhouse MEJ; Gilbert S; Charleston B; Brown IH; Brookes SM
    Vaccine; 2019 Apr; 37(17):2288-2293. PubMed ID: 30914224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs.
    Dhakal S; Hiremath J; Bondra K; Lakshmanappa YS; Shyu DL; Ouyang K; Kang KI; Binjawadagi B; Goodman J; Tabynov K; Krakowka S; Narasimhan B; Lee CW; Renukaradhya GJ
    J Control Release; 2017 Feb; 247():194-205. PubMed ID: 28057521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.
    Ruan BY; Yao Y; Wang SY; Gong XQ; Liu XM; Wang Q; Yu LX; Zhu SQ; Wang J; Shan TL; Zhou YJ; Tong W; Zheng H; Li GX; Gao F; Kong N; Yu H; Tong GZ
    Vet Microbiol; 2020 Jul; 246():108724. PubMed ID: 32605742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza A Virus Infection to Unvaccinated Pigs.
    Everett HE; van Diemen PM; Aramouni M; Ramsay A; Coward VJ; Pavot V; Canini L; Holzer B; Morgan S; ; Woolhouse MEJ; Tchilian E; Brookes SM; Brown IH; Charleston B; Gilbert S
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33268518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Hewitt JS; Karuppannan AK; Tan S; Gauger P; Halbur PG; Gerber PF; De Groot AS; Moise L; Opriessnig T
    Vaccine; 2019 Jul; 37(31):4302-4309. PubMed ID: 31248687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.
    Gorres JP; Lager KM; Kong WP; Royals M; Todd JP; Vincent AL; Wei CJ; Loving CL; Zanella EL; Janke B; Kehrli ME; Nabel GJ; Rao SS
    Clin Vaccine Immunol; 2011 Nov; 18(11):1987-95. PubMed ID: 21918118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Sui J; Yang D; Qiao C; Xu H; Xu B; Wu Y; Yang H; Chen Y; Chen H
    Vaccine; 2016 Jul; 34(33):3757-63. PubMed ID: 27321744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
    Abente EJ; Rajao DS; Santos J; Kaplan BS; Nicholson TL; Brockmeier SL; Gauger PC; Perez DR; Vincent AL
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the European Avian-like H1N1 swine influenza virus in mice and pigs.
    Ruan BY; Wen F; Gong XQ; Liu XM; Wang Q; Yu LX; Wang SY; Zhang P; Yang HM; Shan TL; Zheng H; Zhou YJ; Tong W; Gao F; Tong GZ; Yu H
    Vet Microbiol; 2018 Aug; 222():75-84. PubMed ID: 30080677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.
    Easterbrook JD; Kash JC; Sheng ZM; Qi L; Gao J; Kilbourne ED; Eichelberger MC; Taubenberger JK
    Influenza Other Respir Viruses; 2011 May; 5(3):198-205. PubMed ID: 21477139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a pandemic (H1N1) 2009 virus vaccine in pigs against the pandemic influenza virus is superior to commercially available swine influenza vaccines.
    Loeffen WL; Stockhofe N; Weesendorp E; van Zoelen-Bos D; Heutink R; Quak S; Goovaerts D; Heldens JG; Maas R; Moormann RJ; Koch G
    Vet Microbiol; 2011 Sep; 152(3-4):304-14. PubMed ID: 21664078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs.
    Vincent AL; Ciacci-Zanella JR; Lorusso A; Gauger PC; Zanella EL; Kehrli ME; Janke BH; Lager KM
    Vaccine; 2010 Mar; 28(15):2782-7. PubMed ID: 20132919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.
    Yang H; Chen Y; Shi J; Guo J; Xin X; Zhang J; Wang D; Shu Y; Qiao C; Chen H
    Vet Microbiol; 2011 Sep; 152(3-4):229-34. PubMed ID: 21596495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice.
    Wu Y; Yang D; Xu B; Liang W; Sui J; Chen Y; Yang H; Chen H; Wei P; Qiao C
    Antiviral Res; 2017 Nov; 147():29-36. PubMed ID: 28941982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
    Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
    J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.